Media

Streetwise Reports – Algernon Pharmaceuticals Looks to U.S. for Help Fighting Strokes
Market One – Rethinking DMT: Algernon Pharmaceuticals’ Novel Approach to Stroke Treatment
Proactive Investors Interview – Algernon Pharmaceuticals Receives a Positive Response from U.S. FDA on SCLC Study
Share via
Copy link
Powered by Social Snap